Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study von BREWER, G. J, DICK, R. D, STRAWDERMAN, M, LECARPENTIER, G, MERAJVER, S. D, GROVER, D. K, LECLAIRE, V, TSENG, M, WICHA, M, PIENTA, K, REDMAN, B. G, JAHAN, T, SONDAK, V. K

Volltext

Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma von REDMAN, B. G, SMITH, D. C, FLAHERTY, L, WEIDU, HUSSAIN, M

Volltext

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer von Smith, David C, Redman, Bruce G, Flaherty, Lawrence E, LI, Lang, Strawderman, Myla, Pienta, Kenneth J

Volltext

Southwest Oncology Group Study of Paclitaxel and Carboplatin for Advanced Transitional-Cell Carcinoma: The Importance of Survival as a Clinical Trial End Point von SMALL, E. J, LEW, D, REDMAN, B. G, PETRYLAK, D. P, HAMMOND, N, GROSS, H. M, EASTHAM, J. A, CRAWFORD, E. D

Volltext

A phase ii trial of oral estramustine and oral etoposide in hormone refractory prostate cancer von Pienta, Kenneth J., Redman, Bruce G., Bandekar, Rajesh, Strawderman, Myla, Cease, Kemp, Esper, Peggy S., Naik, Harmesh, Smith, David C.

Volltext

Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma von REDMAN, B. G, HILLMAN, G. G, FLAHERTY, L, FORMAN, J, DEZSO, B, HAAS, G. P

Volltext

Local administration of dendritic cells inhibits established breast tumor growth : Implications for apoptosis-inducing agents von CANDIDO, Kimberly A, SHIMIZU, Koichi, MCLAUGHLIN, Julie C, KUNKEL, Robin, FULLER, Jennifer A, REDMAN, Bruce G, THOMAS, Elaine K, NICKOLOFF, Brian J, MULE, James J

Volltext

A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin‐2 in metastatic malignant melanoma von Flaherty, Lawrence E., Redman, Bruce G., Martino, Silvana, Kraut, Michael, Valdivieso, Manuel, Robinson, William, Gonzalez, Rene, Rudolph, Alfred R.

Volltext

Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group Study von Bukowski, Ronald M., Goodman, Phyllis, Crawford, E. David, Sergi, James S., Redman, Bruce G., Whitehead, Robert P.

Volltext

Immunotherapy of renal cell carcinoma von Haas, G. P, Hillman, G. G, Redman, B. G, Pontes, J. E

Volltext

Oral etoposide in the treatment of hormone‐refractory prostate cancer von Hussain, Maha H., Pienta, Kenneth J., Redman, Bruce G., Cummings, Glenn D., Flaherty, Lawrence E.

Volltext

Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen‐independent prostate carcinoma von Hellerstedt, Beth, Pienta, Kenneth J., Redman, Bruce G., Esper, Peg, Dunn, Rodney, Fardig, Judith, Olson, Karin, Smith, David C.

Volltext

Phase I study of monoclonal antibody-ricin A chain immunoconjugate xomazyme-791 in patients with metastatic colon cancer von LORUSSO, P. M, LOMEN, P. L, REDMAN, B. G, POPLIN, E, BANDER, J. J, VALDIVIESO, M

Volltext

Difluorodeoxycytidine (dFcD) : gemcitabine : a phase I study von POPLIN, E. A, CORBETT, T, FLAHERTY, L, TARASOFF, P, REDMAN, B. G, VALDIVIESO, M, BAKER, L

Volltext

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials von Marcath, Lauren A, Coe, Taylor D, Hoylman, Emily K, Redman, Bruce G, Hertz, Daniel L

Volltext

Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Ca... von MOTZER, Robert J, MICHAELSON, M. Dror, LI, Jim Z, BELLO, Carlo L, THEUER, Charles P, GEORGE, Daniel J, RINI, Brian I, REDMAN, Bruce G, HUDES, Gary R, WILDING, George, FIGLIN, Robert A, GINSBERG, Michelle S, KIM, Sindy T, BAUM, Charles M, DEPRIMO, Samuel E

Volltext

Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinoma von Redman, B G, Abubakr, Y, Chou, T, Esper, P, Flaherty, L E

Volltext

Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial von Powles, T.B., Escudier, B., de Souza, P., Chowdhury, S., Pook, D., Harmenberg, U., Basappa, N., Geynisman, D., Merchan, J., Redman, B.G., Ryan, C., Goodman, O., Ho, T., Singh, P., Lougheed, J., Patel, M., Knox, J.J., Motzer, R.J., Choueiri, T.K.

Volltext

Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma von LORUSSO, P, PAZDUR, R, REDMAN, B. G, KINZIE, J, VAINUTIS VAITKEVICIUS

Volltext

Phase Ib Trial Assessing Autologous, Tumor-pulsed Dendritic Cells as a Vaccine Administered With or Without IL-2 in Patients With Metastatic Melanoma von REDMAN, Bruce G, CHANG, Alfred E, WHITFIELD, Joel, ESPER, Peg, GUIHUA JIANG, BRAUN, Thomas, ROESSLER, Blake, MULE, James J

Volltext